{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:48:16Z","timestamp":1750895296483},"reference-count":165,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":535,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust. N.Z. J. Surg."],"published-print":{"date-parts":[[2000,7,7]]},"abstract":"<jats:p> <jats:bold>Background<\/jats:bold>: Controversy continues to surround the best practice for management of the axilla in patients with early breast cancer (EBC), particularly the clinically negative axilla. The balance between therapeutic and staging roles of axillary surgery (with the consequent morbidity of the procedures utilized) has altered. This is due to the increasing frequency of women presenting with early stage disease, the more widespread utilization of adjuvant chemoendocrine therapy and, more recently, the advent of alternative staging procedures, principally sentinel node biopsy (SNB). The aim of the present review is to critically analyse the current literature concerning the preferred management of the axilla in early breast cancer and make evidence\u2010based recommendations on current management.<\/jats:p><jats:p> <jats:bold>Methods<\/jats:bold>: A review was undertaken of the English language medical literature, using MEDLINE database software and cross\u2010referencing major articles on the subject, focusing on the last 10 years. The following combinations of key words have been searched: breast neoplasms, axilla, axillary dissection, survival, prognosis, and sentinel node biopsy.<\/jats:p><jats:p> <jats:bold>Results<\/jats:bold>: Despite the trend to more frequent earlier stage diagnosis, levels I and II axillary dissection remain the treatment of choice in the majority of women with EBC and a clinically negative axilla.<\/jats:p><jats:p> <jats:bold>Conclusions<\/jats:bold>: Sentinel node biopsy has no proven superiority over axillary dissection because no randomized controlled trials have been completed to date. Despite this, SNB will become increasingly utilized due to encouraging results from major centres responsible for its development, and patient demand. Therefore if patients are not being enrolled in clinical trials strict quality controls need to be established at a local level before SNB is allowed to replace standard treatment of the axilla. Unless this is strictly adhered to there is a significant risk of an increase in the frequency of axillary relapse and possible increased understaging and resultant inadequate treatment of patients.<\/jats:p>","DOI":"10.1046\/j.1440-1622.2000.01838.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T02:44:39Z","timestamp":1047350679000},"page":"515-524","source":"Crossref","is-referenced-by-count":16,"title":["ROLE OF AXILLARY SURGERY IN EARLY BREAST CANCER: REVIEW OF THE CURRENT EVIDENCE"],"prefix":"10.1111","volume":"70","author":[{"given":"Andrew J.","family":"Spillane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel P. M.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"29","article-title":"Prognostic and therapeutic significance of pathological features of breast cancer.","volume":"1","author":"Fisher ER.","year":"1986","journal-title":"Monogr. Natl Cancer Inst."},{"key":"e_1_2_5_3_2","first-page":"126","article-title":"Radical axillary dissection in the staging and treatment of breast cancer.","volume":"74","author":"Ball ABS","year":"1992","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-9776(92)90011-P"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92172-X"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6773.360"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1996.01430150079015"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940201)73:3<664::AID-CNCR2820730326>3.0.CO;2-S"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01807645"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.691"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92759-M"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1999.00984.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92204-4"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0033-8389(22)02494-0","article-title":"Update of the Swedish two county program of mammographic screening for breast cancer.","volume":"30","author":"Tabar L","year":"1992","journal-title":"Radiol. Clin. North Am."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.477"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/jama.1971.03180240027005","article-title":"Periodic breast cancer screening in reducing mortality from breast cancer.","volume":"215","author":"Shapiro S","year":"1971","journal-title":"JAMA"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91703-3"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900301)65:5<1085::AID-CNCR2820650507>3.0.CO;2-S"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890515)63:10<1873::AID-CNCR2820631002>3.0.CO;2-6"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951101)76:9<1579::AID-CNCR2820760913>3.0.CO;2-G"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940315)73:6<1660::AID-CNCR2820730618>3.0.CO;2-Z"},{"key":"e_1_2_5_22_2","first-page":"56","article-title":"Approach to mammographically discovered small breast cancer.","volume":"2","author":"Cady B.","year":"1996","journal-title":"Cancer"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198503143121102"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1200\/JCO.1986.4.5.655","article-title":"Complete axillary lymph node dissection for stage I\u2013II carcinoma of the breast.","volume":"4","author":"Danforth DN","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_5_25_2","first-page":"127","article-title":"Extent of metastatic axillary involvement in 1446 cases of breast cancer.","volume":"16","author":"Veronesi U","year":"1990","journal-title":"Eur. J. Surg. Oncol."},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/oxfordjournals.annonc.a057685","article-title":"The treatment of metastatic breast cancer with adjuvant systemic therapy.","volume":"1","author":"Henderson IC.","year":"1990","journal-title":"Ann. Oncol."},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198212001-00004"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02307063"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02306375"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(96)00228-0"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2206::AID-CNCR15>3.0.CO;2-7"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199709000-00007"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199805000-00005"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800800409"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900701)66:1<102::AID-CNCR2820660119>3.0.CO;2-5"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1990.01410220082011"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03301-7"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90997-H"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11423-4"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1998.00746.x"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050572"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/29.1.11"},{"key":"e_1_2_5_44_2","unstructured":"DixonJM.Author\u2019s reply (Letter).BMJ1999;318: 600."},{"key":"e_1_2_5_45_2","unstructured":"DixonJM.Sentinel node biopsy in breast cancer.BMJ1999;318: 600."},{"key":"e_1_2_5_46_2","doi-asserted-by":"crossref","unstructured":"HingstonGR CookeTG GoingJJ SimonR FlettMM.Accuracy of intraoperative frozen\u2010section analysis of axillary nodes (Letter).Br. J. Surg.1999;86: 1092.","DOI":"10.1046\/j.1365-2168.1999.01197.x"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710023371401"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09201-0"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710023371402"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870215)59:4<682::AID-CNCR2820590403>3.0.CO;2-Z"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198001033020104"},{"key":"e_1_2_5_53_2","first-page":"1565","article-title":"Prognostic importance of occult axillary lymph node micrometastases from breast cancers.","volume":"335","author":"International (Ludwig) Breast Cancer Study Group.","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.16"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810013391410"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(86)80162-1"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196911)24:5<1071::AID-CNCR2820240533>3.0.CO;2-H"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950101)75:1<65::AID-CNCR2820750112>3.0.CO;2-B"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820901)50:5<962::AID-CNCR2820500526>3.0.CO;2-X"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940115)73:2<350::AID-CNCR2820730219>3.0.CO;2-5"},{"key":"e_1_2_5_61_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JCO.1995.13.1.47","article-title":"Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy.","volume":"13","author":"Leonard C","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930801)72:3<778::AID-CNCR2820720324>3.0.CO;2-J"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00081-9"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2334"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840315)53:6<1329::AID-CNCR2820530618>3.0.CO;2-U"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199412000-00001"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90108-S"},{"key":"e_1_2_5_68_2","unstructured":"RosenPP.Pathological examination of breast specimens. InBreast Pathology.Philadelphia: Lippincott\u2010Raven 1996."},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199509000-00016"},{"key":"e_1_2_5_70_2","first-page":"539","article-title":"Efficacy of reverse transcriptase\u2010polymerase chain reaction screening for micrometastatic disease in axillary lymph nodes of breast cancer patients.","volume":"64","author":"Lockett MA","year":"1998","journal-title":"Am. Surg."},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940901)74:5<1595::AID-CNCR2820740516>3.0.CO;2-L"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198506203122504"},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-999-0095-3"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1980.250"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.10.729"},{"key":"e_1_2_5_76_2","first-page":"59","article-title":"Carcinoma of the breast.","volume":"57","author":"Handley RS.","year":"1975","journal-title":"Ann. R. Coll. Surg."},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197601)37:1<206::AID-CNCR2820370130>3.0.CO;2-M"},{"key":"e_1_2_5_78_2","first-page":"1555","article-title":"The end result of enlarged radical mastectomy.","volume":"19","author":"Margotinni WS","year":"1963","journal-title":"Acta Unio Int Contra Cancrum"},{"key":"e_1_2_5_79_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830515)51:10<1941::AID-CNCR2820511032>3.0.CO;2-T"},{"key":"e_1_2_5_80_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303699"},{"key":"e_1_2_5_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800770216"},{"key":"e_1_2_5_82_2","doi-asserted-by":"publisher","DOI":"10.1054\/brst.1999.0044"},{"key":"e_1_2_5_83_2","unstructured":"HarrisJ MorrowM NortonL.Malignant tumours of the breast. In: Devita Jr VT Hellman S Rosenburg SA (eds)Cancer: Principles and Practice of Oncology 5th edn. Philadelphia: Lippincott\u2013Raven 1997; Ch. 36."},{"key":"e_1_2_5_84_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951101)76:9<1491::AID-CNCR2820760902>3.0.CO;2-8"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(87)90060-5"},{"key":"e_1_2_5_86_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.133.6.647"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)01350-6"},{"key":"e_1_2_5_88_2","unstructured":"HortobagyiGN BazdarAU ChaplinRet al.Lack of efficacy of adjuvant high\u2010dose (HD) tandem combination chemotherapy (CT) for high\u2010risk primary breast cancer (HRPBC): A randomised trial (Abstract).Proc. Am. Soc. Clin. Oncol.Philadelphia: WB Saunders Co. 1998;17: 471."},{"key":"e_1_2_5_89_2","unstructured":"PetersWP BerryD VredenburghJJet al.Five\u2010year follow\u2010up of high dose combination alkylating agents with autologous bone marrow transplantation as consolidation after standard dose cyclophosphamide doxorubicin and fluorouracil for primary breast cancer involving > 10 axillary lymph nodes (Abstract).Proc. Am. Soc. Clin. Oncol. Philadelphia: WB Saunders Co. 1995;14: 317."},{"key":"e_1_2_5_90_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.5.1655"},{"key":"e_1_2_5_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01004-0"},{"key":"e_1_2_5_92_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540220042028"},{"key":"e_1_2_5_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)89483-7"},{"key":"e_1_2_5_94_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806351"},{"key":"e_1_2_5_95_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.107"},{"key":"e_1_2_5_96_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.537"},{"key":"e_1_2_5_97_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.547"},{"key":"e_1_2_5_98_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.424"},{"key":"e_1_2_5_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197702)39:2<527::AID-CNCR2820390221>3.0.CO;2-N"},{"key":"e_1_2_5_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(16)43192-0"},{"key":"e_1_2_5_101_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-196912000-00004"},{"key":"e_1_2_5_102_2","unstructured":"HaagensenCD.Diseases of the Breast revised 2nd edn. Philadelphia: W.B. Saunders 1971."},{"key":"e_1_2_5_103_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005733404976"},{"key":"e_1_2_5_104_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00666005"},{"key":"e_1_2_5_105_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1987.230"},{"key":"e_1_2_5_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800720511"},{"key":"e_1_2_5_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-9776(94)90035-3"},{"key":"e_1_2_5_108_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800821118"},{"key":"e_1_2_5_109_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800720512"},{"key":"e_1_2_5_110_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800800416"},{"key":"e_1_2_5_111_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810013391401"},{"key":"e_1_2_5_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-7404(93)90064-6"},{"key":"e_1_2_5_113_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2345"},{"key":"e_1_2_5_114_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199709000-00006"},{"key":"e_1_2_5_115_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.134.7.764"},{"key":"e_1_2_5_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-999-0345-4"},{"key":"e_1_2_5_117_2","unstructured":"European Organisation for the ResearchandTreatment of Cancer (EORTC) Breast Cancer Cooperative Group.EORTC Protocol 10981: After Mapping of the Axilla: Radiotherapy or Surgery (AMAROS). Brussels: EORTC Data Center 1999."},{"key":"e_1_2_5_118_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900227"},{"key":"e_1_2_5_119_2","doi-asserted-by":"publisher","DOI":"10.7863\/jum.1996.15.3.241"},{"key":"e_1_2_5_120_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0096(199702)25:2<53::AID-JCU1>3.0.CO;2-I"},{"key":"e_1_2_5_121_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.203.2.9114081"},{"key":"e_1_2_5_122_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.17.1204"},{"key":"e_1_2_5_123_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199808000-00012"},{"key":"e_1_2_5_124_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.1996.tb00061.x"},{"key":"e_1_2_5_125_2","first-page":"1758","article-title":"Technetium\u201099m\u2010sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.","volume":"36","author":"Taillefer R","year":"1995","journal-title":"J. Nucl. Med."},{"key":"e_1_2_5_126_2","first-page":"791","article-title":"The interrelationship of hematogenous and lymphatic tumor cell dissemination.","volume":"122","author":"Fisher B","year":"1966","journal-title":"Surg. Gynecol. Obstet."},{"key":"e_1_2_5_127_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.23.1771"},{"key":"e_1_2_5_128_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199808000-00015"},{"key":"e_1_2_5_129_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00682701"},{"key":"e_1_2_5_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(05)80236-3"},{"key":"e_1_2_5_131_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2521::AID-CNCR17>3.0.CO;2-A"},{"key":"e_1_2_5_132_2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/clinchem\/44.6.1177","article-title":"Urokinase plasminogen activator: A prognostic marker in breast cancer including patients with axillary node\u2010negative disease.","volume":"44","author":"Duffy MJ","year":"1998","journal-title":"Clin. Chem."},{"key":"e_1_2_5_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90146-9"},{"key":"e_1_2_5_134_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008220917687"},{"key":"e_1_2_5_135_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690048"},{"key":"e_1_2_5_136_2","first-page":"1259","article-title":"The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast cancer.","volume":"57","author":"Tan P","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_5_137_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.160413"},{"key":"e_1_2_5_138_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2659"},{"key":"e_1_2_5_139_2","unstructured":"SlamonD Leyland\u2010JonesB ShakSet al.Addition of HerceptinTM (humanized Anti\u2010HER2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer (HER2 +\/ MBC) markedly increases anticancer activity: A randomized multinational controlled phase III trial.Proc. Am. Soc. Clin. Oncol.Philadelphia: WB Saunders Co. 1998."},{"key":"e_1_2_5_140_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197706)39:6<2827::AID-CNCR2820390671>3.0.CO;2-I"},{"key":"e_1_2_5_141_2","first-page":"55","article-title":"CRC (Kings\/ Cambridge) trial for early breast cancer. A detailed update at the tenth year.","volume":"11","author":"Cancer Research Campaign Working Party.","year":"1980","journal-title":"Lancet"},{"key":"e_1_2_5_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90534-9"},{"key":"e_1_2_5_143_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841869009092990"},{"key":"e_1_2_5_144_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920515)69:10<2496::AID-CNCR2820691018>3.0.CO;2-T"},{"key":"e_1_2_5_145_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800730723"},{"key":"e_1_2_5_146_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.1998.0597"},{"key":"e_1_2_5_147_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303847"},{"key":"e_1_2_5_148_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197810)42:4<2059::AID-CNCR2820420457>3.0.CO;2-Q"},{"key":"e_1_2_5_149_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197203)29:3<545::AID-CNCR2820290302>3.0.CO;2-Q"},{"key":"e_1_2_5_150_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820101)49:1<30::AID-CNCR2820490107>3.0.CO;2-L"},{"key":"e_1_2_5_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91807-0"},{"key":"e_1_2_5_152_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1993.01420240023002"},{"key":"e_1_2_5_153_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.6.988"},{"key":"e_1_2_5_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91591-U"},{"key":"e_1_2_5_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90895-O"},{"key":"e_1_2_5_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(98)90005-0"},{"key":"e_1_2_5_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90783-Z"},{"key":"e_1_2_5_158_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511303332202"},{"key":"e_1_2_5_159_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.3.447"},{"key":"e_1_2_5_160_2","first-page":"407","article-title":"Breast cancer, risk of axillary recurrence in node negative patients following partial dissection of the axilla.","volume":"14","author":"Graverson HP","year":"1988","journal-title":"Eur. J. Surg. Oncol."},{"key":"e_1_2_5_161_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(86)90280-4"},{"key":"e_1_2_5_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(87)90256-2"},{"key":"e_1_2_5_163_2","first-page":"765","article-title":"The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.","volume":"152","author":"Fisher B","year":"1981","journal-title":"Surg. Gynecol. Obstet."},{"key":"e_1_2_5_164_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199008000-00009"},{"key":"e_1_2_5_165_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.10.2229"},{"key":"e_1_2_5_166_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1989.01410010027005"}],"container-title":["Australian and New Zealand Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1622.2000.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1622.2000.01838.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:31:58Z","timestamp":1698784318000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1622.2000.01838.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,7]]},"references-count":165,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7,7]]}},"alternative-id":["10.1046\/j.1440-1622.2000.01838.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1622.2000.01838.x","archive":["Portico"],"relation":{},"ISSN":["0004-8682"],"issn-type":[{"value":"0004-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7,7]]}}}